TP53 and cancer: A recent breakthrough was the discovery that mutant p53 undergoes aggregation in a very similar way to that observed with other amyloid proteins [11,25,27], playing a crucial role in the development of cancer through loss of p53 function, a dominance-negative effect and gain of oncogenic function.